Jacob D. Cohen - 05 Jun 2025 Form 4 Insider Report for MANGOCEUTICALS, INC. (MGRX)

Reporting relationship: Chief Executive Officer, Director, 10%+ Owner
Issuer ticker: MGRX
Reported as of: 05 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Mar 2026, 17:00:40 UTC
Prior SEC filing: 30 Sep 2025
Next SEC filing: 20 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jacob D. Cohen

Key filing fact

Jacob D. Cohen filed Form 4 for MANGOCEUTICALS, INC. (MGRX) on 20 Mar 2026.

Key facts

This page summarizes Jacob D. Cohen's Form 4 filing for MANGOCEUTICALS, INC. (MGRX).
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 20 Mar 2026, 17:00.

Change

Previous filing in this sequence was filed on 30 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001432078 Primary reporting owner

Cohen Jacob D.

Relationship: Chief Executive Officer, Director, 10%+ Owner
Address: C/O MANGOCEUTICALS, INC., 17130 N. DALLAS PARKWAY, SUITE 240, DALLAS
Signature: /s/ Jacob D. Cohen
Signature date: 20 Mar 2026

CIK 0001974475

Tiger Cub Trust

Relationship: 10%+ Owner
Address: C/O MANGOCEUTICALS, INC., 17130 N. DALLAS PARKWAY, SUITE 240, DALLAS
Signature: /s/ Jacob D. Cohen, Trustee, The Tiger Cub Trust
Signature date: 20 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MGRX transaction

Common Stock

Gift

Transaction value
Shares: -200,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 05 Jun 2025
Ownership: Direct
Footnotes: F1, F2

MGRX transaction

Common Stock

Gift

Transaction value
Shares: +200,000
Change %: +33%
Price: $0.000000^*
Shares after: 805,000
Date: 05 Jun 2025
Ownership: Direct
Footnotes: F1, F3

MGRX transaction

Common Stock

Award

Transaction value
Shares: +500,000
Change %
Price: $0.000000^*
Shares after: 500,000
Date: 09 Sep 2025
Ownership: Direct
Footnotes: F2, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MGRX transaction Derivative

Convertible Promissory Note

Award

Transaction value
Shares
Change %
Price
Shares after: $100,000
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 56,023
Exercise price: $1.78
Footnotes: F3, F5, F6

MGRX transaction Derivative

Warrant to Purchase Common Stock

Award

Transaction value
Shares: +50,000
Change %
Price
Shares after: 50,000
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $1.85
Footnotes: F3, F5

MGRX transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +2,000,000
Change %
Price: $0.000000^*
Shares after: 2,000,000
Date: 09 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,000,000
Exercise price: $2.30
Footnotes: F2, F4, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities.

Footnote F2

Represents Mr. Cohen's direct ownership of the Issuer.

Footnote F3

Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee ("Tiger Cub"). Mr. Cohen disclaims beneficial ownership of the securities held by Tiger Cub except to the extent of his pecuniary interest therein.

Footnote F4

Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer during 2025. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3.

Footnote F5

On July 21, 2025, the Company entered into an Agreement to Amend Promissory Note, with Tiger Cub, pursuant to which Tiger Cub and the Company agreed to amend and restate a prior $100,000 Promissory Note into an Amended and Restated Convertible Promissory Note (the "A&R Note"); and the Company granted Tiger Cub warrants to purchase 50,000 shares of common stock. The A&R Note, among other things, amended and restated the Promissory Note to provide Tiger Cub the option to convert the principal and accrued interest under the note into shares of common stock of the Company at a conversion price of $1.785 per share. The Note accrues interest at 18% per annum and the number of shares shown in the table above does not include interest which is also convertible into common stock of the Company.

Footnote F6

Represents the maturity date of the Convertible Promissory Note.

Footnote F7

The options vest over 18 months with 500,000 of the options vesting upon grant and 500,000 of the options vesting on the 6th, 12th, and 18th month anniversaries of the grant date, subject to Mr. Cohen's continued service with the Company on such vesting date; and vest in full upon any termination of Mr. Cohen by the Company without cause, or by Mr. Cohen for good reason, or upon a change of control of the Company.